Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2004
12/15/2004EP1218005B1 Vitronectin receptor antagonists
12/15/2004EP1119543B1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor
12/15/2004EP1117639B1 Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators
12/15/2004EP1034783B1 Amide derivatives for the treatment of retinal neurodegenerative disorders
12/15/2004CN1555364A Insecticidal diamides
12/15/2004CN1555361A Butyric acid derivatives
12/15/2004CN1555357A Substituied ureaalkyl urea vitamin A protagonist ii
12/15/2004CN1554649A Metabotropic glutamate receptor antagonists for treating central nervous system diseases
12/15/2004CN1554648A Process for preparing alcohol by heterocyclic carboxylic ester reduction
12/15/2004CN1180050C Metal ligand compound, luminous device and display device
12/15/2004CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them
12/15/2004CN1179774C Extraction and distillation process of separating-2-chloro-5-methylpyridine and 2-chloro-3-methylpridine
12/14/2004US6831199 Pyrimidine compounds and derivatives thereof
12/14/2004US6831193 Trisubstituted-N-[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]benzamides which inhibit P2X3 and P2X2/3 containing receptors
12/14/2004US6831175 Such as N,N-dimethyl-N-(2-((5-((E)-2-pyridin-4-ylvinyl) pyridin-3-yl)oxy)ethyl)amine
12/14/2004US6831143 Polymerization catalysts
12/14/2004US6831106 Vitamin D analogues
12/14/2004US6831080 Cinnamide derivatives as KCNQ potassium channel modulators
12/14/2004US6831074 Inhibitors of cyclic guanosine 3',5'-monophosphate phosphodiesterases (cGMP PDES); for use in therapy of sexual disorders
12/10/2004WO2004108677A1 Antithrombotic ethers
12/09/2004WO2004106939A2 Method for the linkage of bifunctional chelating agents and (radioactive) transition metal complexes to proteins and peptides
12/09/2004WO2004106363A2 A tag for purification of peptides
12/09/2004WO2004106304A2 3 - [2- (3-amino-2-oxo-2h-pyridin-1-yl) - acetylamino] - 4- oxo-pentanoic acid derivatives and their use as caspase inhibitors
12/09/2004WO2004106296A2 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
12/09/2004WO2004106293A2 Oxazolyl - and thiazolyl - purine based tricyclic compounds.
12/09/2004WO2004106283A1 Amino alcohol derivative, medicinal composition containing the same, and uses of these
12/09/2004WO2004105754A1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
12/09/2004WO2004105488A1 Hydrazone derivatives for combatting harmful insects and arachnids
12/09/2004WO2004069794A9 New arylpiperazinyl compounds
12/09/2004US20040249164 Crystalline hydrates of nicotinic acid anilide and benzoyl anilide derivatives
12/09/2004US20040249163 Process for preparing beta-ketoester compound
12/09/2004US20040249161 Biphenyl-derivatives as p38-kinase inhibitors
12/09/2004US20040249156 reacting a phenyl pyridine compound with IrCl3 gydrate or Na3IrCl6 Hydrate forming an intermedeate, reacting intermediate with a carbonyl compound to form a metal complex; increasing the operating life time of the device
12/09/2004US20040249150 Positive allosteric modulators of the nicotinic acetylcholine receptor
12/09/2004US20040248952 Novel bicyclic compounds and compositions
12/09/2004US20040248947 N-(3- and 4-substituted phenyl)-2-(arylamino)-benzamides; aralkylation of the 2-primary amine with a benzaldehyde or a pyrid-4-yl carbaldehyde; anticarcinogenic, antitumor agents; enzyme inhibitors of vascular endothelial growth factors
12/09/2004US20040248937 protein tyrosine phosphatase inhibitors such as N-[(4-{[4,6-bis(4-methoxyphenyl)pyrimidin-2-yl]amino}phenyl)sulfonyl]-N-methyl-L-phenylalanine, used for treatment of metabolic disorders related to insulin resistance or hyperglycemia
12/09/2004US20040248913 (Pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulators
12/09/2004US20040248897 Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions
12/09/2004US20040248882 Noninsulin dependent diabetes, obesity, hypercholesterolemia, inflammatory disorders; reduced side effects; such as 5-(4-acetylbenzenesulfonamido-2-fluorophenoxy)-3-chloropyridine
12/09/2004US20040248872 Safe for agricultural or gardening use; effective against insects and mammals
12/09/2004US20040248811 increased oral bioavailability and reduced dosage and regime; epilepsy; pain syndrome therapy
12/09/2004US20040248740 for controlling undesirable plants
12/09/2004US20040248739 Pyridylpropynyloxyphenyl derivatives for use as herbicides
12/09/2004US20040247523 Diagnosing and localizing sites of inflammation and perfusion abnormalities (e.g. reperfusion injury, vulnerable plaque, bacterial endocarditis or cardiac transplant rejection) in a single dual isotope imaging procedure, particularly CT imaging, ultrasound, or scintigraphy.
12/09/2004DE10323692A1 Chirale Liganden und deren Übergangsmetallkomplexe Chiral ligands and their transition metal complexes
12/09/2004CA2527674A1 A tag for purification of peptides
12/09/2004CA2527632A1 Benzamide nitrile derivatives
12/09/2004CA2527168A1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
12/09/2004CA2526749A1 3-[2-(3-amino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
12/08/2004EP1484614A1 Fluorescent sensor for phosphate ion and phosphorylated peptide
12/08/2004EP1484319A1 Chain oligolactic acid thioester
12/08/2004EP1484317A1 Lactic acid derivative
12/08/2004EP1484301A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
12/08/2004EP1483578A2 Artificial receptors, building blocks, and methods
12/08/2004EP1483266A1 Spiro compounds with npy antagonistic activity
12/08/2004EP1483263A1 Thiazolyl urea compounds for the treatment of cancer
12/08/2004EP1483256A2 Process for making chiral 1,4-disubstituted piperazines
12/08/2004EP1483243A1 PREPARATION OF N1-(2’-PYRIDYL)-1,2-PROPANEDIAMINE SULFAMIC ACID AND ITS USE IN THE SYNTHESIS OF BIOLOGICALLY ACTIVE PIPERAZINES
12/08/2004EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
12/08/2004EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
12/08/2004EP1482985A2 Technetium-dipyridine complexes, and methods of use thereof
12/08/2004EP1482940A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
12/08/2004EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004EP1482924A2 Cathepsin cysteine protease inhibitors
12/08/2004EP1341754B1 Substituted anthranilic acids
12/08/2004EP1220856B1 Pyrazolo[4,3-d]pyrimidine derivatives
12/08/2004EP0915868B1 Carbanilides used as pesticides
12/08/2004CN1553906A VARIOLIN derivatives and their use as antitumor agents
12/08/2004CN1553898A Method for producing 4-haloalkylnicotinic acid esters
12/08/2004CN1553895A Taxol enhancer compounds
12/08/2004CN1553894A Taxol enhancer compounds
12/08/2004CN1553893A Synthesis of taxol enhancers
12/08/2004CN1552693A Benzoylcyclohexanone amine compounds with herbicidal activity
12/08/2004CN1178932C Amide derivatives
12/08/2004CN1178919C Sythesis of intermediates useful in preparing tricyclic compounds and its intermediates
12/08/2004CN1178917C N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
12/08/2004CN1178916C Ligands and catalyst system thereof for ethylene oligomerisation to linear alpha olefins
12/08/2004CN1178906C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/08/2004CN1178658C Process for synthesizing Cox-2 inhibitors
12/07/2004US6828466 Reacting arene with borane; oxidation, hydrogenation phenylboronic acid
12/07/2004US6828446 Aromatic thioether liver X-receptor modulators
12/07/2004US6828441 2-pyridylmethylamine derivatives useful as fungicides
12/07/2004US6828397 Methods of copolymerizing ethylene and isobutylene and polymers made thereby
12/07/2004US6828350 Inhibiting the activity of a picornavirus 3C protease or a cysteine protease with a composition having an orthohydroxy keto aryl core structure
12/07/2004US6828342 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment
12/07/2004US6828338 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
12/07/2004US6828337 Bicyclic retinods containing ester or acid group; useful for treating emphysema
12/07/2004US6828333 Ether derivatives useful as inhibitors of PDE4 isozymes
12/07/2004US6828316 Antiallergens
12/07/2004US6828275 Synergistic insecticide mixtures
12/07/2004US6828271 To form transition metal complexes which are used in such as asymmetric hydrogenation of imines, asymmetric hydride transfer reactions, hydrosilylation, hydroboration, hydrovinylation hydroformylation, allylic alkylation, etc.
12/02/2004WO2004104014A2 Chiral ligands and their transition metal complexes
12/02/2004WO2004103951A1 Method for producing an optically active nitro compound
12/02/2004WO2004103278A2 Acyl sulfonamides as inhibitors of hiv integrase
12/02/2004WO2004089906A3 6-alkyl or alkenyl-4-aminopicolinates and their use as herbicides
12/02/2004WO2004078746A3 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatrory disorders
12/02/2004WO2004072031A3 Phenylacetamides and their use as glucokinase modulators
12/02/2004WO2004058174A3 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/02/2004WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors